Overview: Initial antimicrobial therapy for microbial keratitis.
作者信息
Daniell M
机构信息
Royal Victorian Eye and Ear Hospital, Melbourne, Victoria 3065, Australia.
出版信息
Br J Ophthalmol. 2003 Sep;87(9):1172-4. doi: 10.1136/bjo.87.9.1172.
Abstract
摘要
相似文献
1
Overview: Initial antimicrobial therapy for microbial keratitis.概述：微生物性角膜炎的初始抗菌治疗
Br J Ophthalmol. 2003 Sep;87(9):1172-4. doi: 10.1136/bjo.87.9.1172.
2
The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.抗菌肽在眼科的应用：角膜保存及细菌性角膜炎治疗的实验研究
Trans Am Ophthalmol Soc. 2002;100:243-71.
3
Bactericidal effect of photo-activated riboflavin using UVA.使用紫外线A的光活化核黄素的杀菌作用
Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):755; author reply 757-8. doi: 10.1007/s00417-009-1281-5. Epub 2010 Jan 21.
4
A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.一种新型广谱抗菌组合药物，用于治疗绿脓杆菌性角膜感染。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00777-19. Print 2019 Oct.
5
Treatment of Pseudomonas keratitis in humans.人类铜绿假单胞菌角膜炎的治疗。
Am J Ophthalmol. 1966 May;61(5 Pt 1):896-903. doi: 10.1016/0002-9394(66)90934-2.
6
Selection of antimicrobial therapy.抗菌治疗的选择。
Instr Course Lect. 1982;31:14-8.
7
Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes.上海小儿细菌性角膜炎病例：微生物特征、抗生素敏感性和视力结果。
Eye (Lond). 2012 Dec;26(12):1571-8. doi: 10.1038/eye.2012.210. Epub 2012 Oct 19.
8
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.广谱抗菌组合药物的开发用于治疗金黄色葡萄球菌和铜绿假单胞菌角膜感染。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01929-18. Print 2019 Jan.
9
Initial therapy for suppurative microbial keratitis in Iraq.伊拉克化脓性微生物角膜炎的初始治疗
Br J Ophthalmol. 2007 Dec;91(12):1583-7. doi: 10.1136/bjo.2007.123208. Epub 2007 Jun 27.
10
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.局部用莫西沙星与环丙沙星和万古霉素治疗兔铜绿假单胞菌及耐环丙沙星耐甲氧西林金黄色葡萄球菌角膜炎的疗效比较
Cornea. 2005 Mar;24(2):201-5. doi: 10.1097/01.ico.0000134462.88535.d0.
引用本文的文献
1
Therapeutic Efficacy of Ultraviolet C Light on Fungal Keratitis-In Vitro and Ex Vivo Studies.紫外线C光对真菌性角膜炎的治疗效果——体外和离体研究
Antibiotics (Basel). 2025 Apr 1;14(4):361. doi: 10.3390/antibiotics14040361.
2
Targeted Bacterial Keratitis Treatment with Polyethylene Glycol-Dithiothreitol-Boric Acid Hydrogel and Gatifloxacin.聚乙二醇-二硫苏糖醇-硼酸水凝胶联合加替沙星靶向治疗细菌性角膜炎。
Curr Drug Deliv. 2024;21(11):1548-1558. doi: 10.2174/0115672018279105240226050253.
3
Ultrasound-assisted gatifloxacin delivery in mouse cornea, in vivo.超声辅助在体小鼠角膜中加替沙星的传递。
Sci Rep. 2019 Oct 29;9(1):15532. doi: 10.1038/s41598-019-52069-w.
4
Spectrum and Sensitivity of Bacterial Keratitis Isolates in Auckland.奥克兰细菌性角膜炎分离株的谱系及敏感性
J Ophthalmol. 2016;2016:3769341. doi: 10.1155/2016/3769341. Epub 2016 Apr 26.
5
Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy.通过活体共聚焦显微镜观察细菌性角膜炎患者人泪液细胞因子水平与角膜细胞变化之间的相关性。
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7457-66. doi: 10.1167/iovs.14-15411.
6
Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa.铜绿假单胞菌所致实验性人类角膜炎中补体凝集素途径的激活
Mol Vis. 2014 Jan 6;20:38-45. eCollection 2014.
7
Initial therapy for suppurative microbial keratitis in Iraq.伊拉克化脓性微生物角膜炎的初始治疗
Br J Ophthalmol. 2007 Dec;91(12):1583-7. doi: 10.1136/bjo.2007.123208. Epub 2007 Jun 27.
本文引用的文献
1
In vivo effects of fluoroquinolones on rabbit corneas.氟喹诺酮类药物对兔角膜的体内效应。
Clin Exp Ophthalmol. 2003 Dec;31(6):517-21. doi: 10.1046/j.1442-9071.2003.00706.x.
2
Suppurative keratitis.化脓性角膜炎
Br J Ophthalmol. 2003 Feb;87(2):127. doi: 10.1136/bjo.87.2.127.
3
Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.铜绿假单胞菌分离株的特征：1997 - 1999年全球哨兵抗菌监测计划中的发生率、抗菌药物敏感性模式及分子分型
Clin Infect Dis. 2001 May 15;32 Suppl 2:S146-55. doi: 10.1086/320186.
4
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.葡萄球菌属感染调查：1997 - 1999年美国、加拿大、拉丁美洲、欧洲及西太平洋地区为哨兵抗菌监测计划收集的分离株的发生频率及抗菌药敏情况
Clin Infect Dis. 2001 May 15;32 Suppl 2:S114-32. doi: 10.1086/320184.
5
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.1997 - 1999年哨兵抗菌监测项目中肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的全球抗菌药物耐药性流行情况
Clin Infect Dis. 2001 May 15;32 Suppl 2:S81-93. doi: 10.1086/320181.
6
Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.局部使用氟喹诺酮治疗微生物性角膜炎后角膜穿孔发生率增加。
Am J Ophthalmol. 2001 Jan;131(1):131-3. doi: 10.1016/s0002-9394(00)00642-5.
7
In vitro antibiotic resistance in bacterial keratitis in London.伦敦细菌性角膜炎的体外抗生素耐药性
Br J Ophthalmol. 2000 Jul;84(7):687-91. doi: 10.1136/bjo.84.7.687.
8
Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.用于治疗细菌性角膜溃疡的氟喹诺酮类和强化抗生素。
Br J Ophthalmol. 2000 Apr;84(4):378-84. doi: 10.1136/bjo.84.4.378.
9
Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.新出现的耐环丙沙星铜绿假单胞菌。
Am J Ophthalmol. 1999 Oct;128(4):509-10. doi: 10.1016/s0002-9394(99)00196-8.
10
Ciprofloxacin-resistant Pseudomonas keratitis.环丙沙星耐药性铜绿假单胞菌角膜炎
Ophthalmology. 1999 Jul;106(7):1319-23. doi: 10.1016/S0161-6420(99)00717-4.
Zotero 插件